First Berlin reiterates Buy on Pharming, keeps EUR 2.2 target price

Bitget2026/09/23 08:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

First Berlin reiterated a Buy rating on Pharming Group, keeping a EUR 2.2 12-month target price.
Update followed acceptance of an abstract on positive phase 2 leniolisib topline data for PI3KD-linked primary immunodeficiencies.
Trial results showed improved lymphoproliferative disease, including a 26.4% mean spleen volume reduction.
Safety profile matched prior experience; infections were most common, with no new safety signals flagged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharming Group NV published the original content used to generate this news brief via EQS News (Ref. ID: rc_26886) on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

First Berlin reiterates Buy on Pharming, keeps EUR 2.2 target price

You may also like

Crypto prices